UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$4.47B |
| 2 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$2.93B |
| 3 |
Vanguard Russell 1000 Value ETF
VONV
|
+$2.75B |
| 4 |
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
|
+$2.69B |
| 5 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$2.33B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.44B |
| 2 |
Micron Technology
MU
|
+$919M |
| 3 |
CYBR
CyberArk
CYBR
|
+$851M |
| 4 |
Honeywell
HON
|
+$606M |
| 5 |
Merck
MRK
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.16% |
| 2 | Technology | 16.96% |
| 3 | Financials | 8.4% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
7101
TransCode Therapeutics
RNAZ
$26.6M
| $71.4K | ﹤0.01% |
8,295
+5,331
| +180% | +$49.7K |
2025 Q4
1 quarter
|
|
7102
Invesco Dorsey Wright Basic Materials Momentum ETF
PYZ
$64.4M
| $71.4K | ﹤0.01% |
596
-106
| -15% | -$13.1K |
2014 Q4
45 quarters
|
|
7103
GDEV Inc
GDEV
$195M
| $71.4K | ﹤0.01% |
5,101
+4,083
| +401% | +$65K |
2024 Q3
6 quarters
|
|
7104
Capital Group Short Duration Municipal Income ETF
CGSM
$1.59B
| $71.3K | ﹤0.01% |
+2,714
| New | +$71.9K |
2026 Q1
0 quarters
|
|
7105
State Street SPDR FactSet Innovative Technology ETF
XITK
$71.6M
| $71.2K | ﹤0.01% |
486
+277
| +133% | +$44.4K |
2019 Q1
28 quarters
|
|
7106
Concrete Pumping Holdings
BBCP
$496M
| $71.2K | ﹤0.01% |
9,974
-19,744
| -66% | -$131K |
2019 Q1
28 quarters
|
|
7107
Energous
WATT
$73.7M
| $71.1K | ﹤0.01% |
4,529
-16,672
| -79% | -$170K |
2014 Q4
45 quarters
|
|
7108
Jasper Therapeutics
JSPR
$18.8M
| $71.1K | ﹤0.01% |
81,117
-45,244
| -36% | -$62.8K |
2024 Q2
7 quarters
|
|
|
SPE
7109
Special Opportunities Fund
SPE
$139M
| $71K | ﹤0.01% |
5,163
+230
| +5% | +$3.37K |
2014 Q4
45 quarters
|
|
7110
Rallybio
RLYB
$90.7M
| $71K | ﹤0.01% |
7,914
+7,342
| +1,284% | +$50.2K |
2022 Q3
14 quarters
|
|
|
BRIE
7111
MFS Blended Research International Equity ETF
BRIE
$438M
| $70.9K | ﹤0.01% |
+2,623
| New | +$73.2K |
2026 Q1
0 quarters
|
|
|
HEQ
7112
John Hancock Hedged Equity & Income Fund
HEQ
$131M
| $70.9K | ﹤0.01% |
6,524
-10,479
| -62% | -$116K |
2014 Q4
45 quarters
|
|
|
BTAI
7113
DELISTED
BioXcel Therapeutics
BTAI
| $70.7K | ﹤0.01% |
52,788
+14,448
| +38% | +$23.8K |
2018 Q1
32 quarters
|
|
7114
VanEck Oil Refiners ETF
CRAK
$615M
| $70.5K | ﹤0.01% |
1,427
+1,031
| +260% | +$45.4K |
2021 Q1
20 quarters
|
|
|
ALDF
7115
Aldel Financial II Inc
ALDF
| $70.4K | ﹤0.01% |
6,668
-294,682
| -98% | -$3.1M |
2025 Q3
2 quarters
|
|
7116
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF
XHLF
$2.03B
| $70K | ﹤0.01% |
1,391
-8
| -0.6% | -$402 |
2025 Q4
1 quarter
|
|
7117
CPI Aerostructures
CVU
$68.5M
| $69.7K | ﹤0.01% |
17,786
-5,361
| -23% | -$22.2K |
2025 Q3
2 quarters
|
|
7118
ParaZero Technologies
PRZO
$17.8M
| $69.7K | ﹤0.01% |
90,377
+17,867
| +25% | +$20.5K |
2024 Q2
7 quarters
|
|
7119
American Conservative Values ETF
ACVF
$154M
| $69.5K | ﹤0.01% |
+1,459
| New | +$72.2K |
2026 Q1
0 quarters
|
|
7120
iShares JPMorgan Broad USD Emerging Markets Bond ETF
BEMB
$40.4M
| $69.4K | ﹤0.01% |
+1,317
| New | +$70.7K |
2026 Q1
0 quarters
|
|
7121
Expensify
EXFY
$205M
| $69.4K | ﹤0.01% |
79,725
-12,391
| -13% | -$14.7K |
2022 Q3
14 quarters
|
|
7122
Brookstone Value Stock ETF
BAMV
$119M
| $69.3K | ﹤0.01% |
2,131
+1,668
| +360% | +$55.1K |
2024 Q3
6 quarters
|
|
|
VCX
7123
Fundrise Innovation Fund
VCX
$1.07B
| $68.9K | ﹤0.01% |
+526
| New | +$103K |
2026 Q1
0 quarters
|
|
|
SUNE
7124
SUNation Energy
SUNE
$15.2M
| $68.7K | ﹤0.01% |
31,239
+27,415
| +717% | +$39.3K |
2025 Q4
1 quarter
|
|
7125
Cingulate
CING
$69.2M
| $68.5K | ﹤0.01% |
11,033
-16,651
| -60% | -$106K |
2024 Q3
6 quarters
|
|
Similar funds
UBS Group's Q1 2026 Portfolio in Review
As of Q1 2026, UBS Group held 11,786 positions worth $666B, up 8% from $617B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $74.2B of net new capital in Q1 2026, opening 1,344 new positions and adding to 4,798 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 38% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was UBS Group, an estimated $1.44B trimmed.
- UBS Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,909,539 shares worth $124M.
- UBS Group added most to iShares Core MSCI EAFE ETF in Q1 2026, an estimated $4.47B increase.
- UBS Group's biggest Q1 2026 reduction was UBS Group, cutting an estimated $1.44B.
- UBS Group fully exited CyberArk in Q1 2026, selling an estimated $851M.
- UBS Group's ten largest holdings make up 13% of its $666B portfolio in Q1 2026.
- UBS Group opened 1,344 new positions and closed 1,383 in Q1 2026.
- UBS Group's portfolio value rose 8% quarter-over-quarter to $666B.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.